ArriVent BioPharma develops cancer medicines, led by firmonertinib for certain types of lung cancer. It last closed at $10.52 on Nov 20, down 6.57% on the day. The next earnings report for AVBP is expected around Thu, Mar 4, 2027, after the close. For the quarter ended Sep 2026, AVBP reported EPS of -$0.81 on revenue of $5.0M. Over its last 8 reports the stock moved an average of 3.8% the session after earnings. Over the last 12 months AVBP insiders bought $0 of stock on the open market and sold $13.0M, according to SEC Form 4 filings.
AI Auto Pilots
Is AVBP in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AVBP.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AVBPStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
AVBP · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 26% below its 20 day and 85% below its 50 day average. It is 149% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 29), oversold. The nearest support is the 52 week low at $10.33, and the nearest resistance the Pivot at $10.75.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 13.0%/day
Key levels
$35.8352 week high+240.6%
$26.20200 day average+149.0%
$25.21100 day average+139.6%
$19.4850 day average+85.2%
$15.05Swing high (Nov 10)+43.1%
$13.2620 day average+26.0%
$11.12Pivot R1+5.7%
$10.75Pivot+2.2%
$10.52Last close
$10.3352 week low−1.8%
$10.15Pivot S1−3.5%
Indicators
RSI (14)
29.44
Oversold below 30
Oversold
MACD
-2.32
Above its signal line
Bullish
Stochastic
11.2
Near the bottom of its range
Oversold
ADX (14)
34.1
Trending down
Williams %R
-96.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-135.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−22.9%
Change over 10 sessions
Bearish
ATR (14)
$1.37
Typical daily range, 13.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 37.4%/day
Key levels
$35.8352 week high+240.6%
$26.20200 day average+149.0%
$25.21100 day average+139.6%
$19.4850 day average+85.2%
$15.05Swing high (Nov 10)+43.1%
$13.2620 day average+26.0%
$11.12Pivot R1+5.7%
$10.75Pivot+2.2%
$10.52Last close
$10.3352 week low−1.8%
$10.15Pivot S1−3.5%
Indicators
RSI (14)
25.59
Oversold below 30
Oversold
MACD
-4.00
Below its signal line
Bearish
Stochastic
6.7
Near the bottom of its range
Oversold
ADX (14)
27.2
Trending down
Williams %R
-99.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-137.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−63.7%
Change over 10 sessions
Bearish
ATR (14)
$3.94
Typical daily range, 37.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for AVBP
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AVBP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AVBPHow many large options trades hit AVBP, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AVBP in the last 90 days.
From SEC Form 4 filings by AVBP's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AVBP is in one of them and how their past AVBP trades turned out.
ArriVent BioPharma is a clinical stage biopharmaceutical company based in Newtown Square, Pennsylvania. It develops cancer treatments for patients, with its lead candidate, firmonertinib, aimed at non-small cell lung cancer linked to certain EGFR gene mutations. The company is also developing antibody drug conjugates, including ARR 217, for solid tumors. Its candidates are still in clinical trials and have not been approved by the U.S. Food and Drug Administration.